Task: Answer the multiple-choice question.
Question: Which drug exhibits a -2.246% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) C=CCN(c1ccc(C(=O)N2CCN(c3ccc(F)cc3)CC2)cc1)S(C)(=O)=O
b) Cc1cc(NC(=O)COc2ccccc2)ccc1Cl
c) CN(C)/C=C/C(=O)c1cc(F)cc(C(F)(F)F)c1
Answer: b. Cc1cc(NC(=O)COc2ccccc2)ccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)COc2ccccc2)ccc1Cl
Cc1cc(NC(=O)COc2ccccc2)ccc1Cl
N-(4-chloro-3-methylphenyl)-2-phenoxyacetamide